LivaNova PLC (LIVN)Healthcare | Medical Devices | Gloucester, United Kingdom | NasdaqGS
78.50 USD
+2.42
(3.181%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 6:40 a.m. EDT
LivaNova is a compelling turnaround candidate where strong recent earnings growth is fighting against a long-term price history of underperformance. The fundamentals are robust, with double-digit revenue growth and a healthy balance sheet, yet the stock has struggled to recover its 2018 highs over the last nine years. The lack of a dividend is a significant drawback for income-focused investors, leaving the total return dependent entirely on capital appreciation. While analysts see significant upside potential, the technical picture remains mixed with the price hovering below its fifty-day average. Options activity reveals a cautious optimism, with traders hedging downside risk while positioning for a move higher toward the $80 mark. This creates a scenario where the business quality is improving, but the market is still digesting the historical drag. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.032953 |
| AutoARIMA | 0.032955 |
| MSTL | 0.035971 |
| AutoTheta | 0.049135 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 10.92 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.436 |
| Excess Kurtosis | -0.93 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 26.556 |
| Revenue per Share | 26.895 |
| Market Cap | 4,324,840,448 |
| Trailing P/E | 23.22 |
| Forward P/E | 16.76 |
| Beta | 0.88 |
| Profit Margins | 12.81% |
| Website | https://www.livanova.com |
As of Oct. 10, 2026, 6:40 a.m. EDT: Speculators are displaying mixed sentiment with elevated implied volatility suggesting uncertainty. Call buyers are targeting upside to the $80 and $90 strikes in the near term, while put buyers are establishing protection near the current price level of $77.50. The high open interest in out-of-the-money calls indicates a bullish bias among traders, though the heavy put volume at nearby strikes suggests a hedge against immediate volatility.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.4610088 |
| Address1 | 5,220 Valiant Court |
| Address2 | Gloucester Business Park |
| All Time High | 131.54 |
| All Time Low | 32.48 |
| Ask | 98.3 |
| Ask Size | 2 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 580,410 |
| Average Daily Volume3 Month | 645,809 |
| Average Volume | 645,809 |
| Average Volume10Days | 580,410 |
| Beta | 0.875 |
| Bid | 56.34 |
| Bid Size | 2 |
| Board Risk | 3 |
| Book Value | 24.074 |
| City | Gloucester |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 2 |
| Country | United Kingdom |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 78.5 |
| Current Ratio | 1.45 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 79.11 |
| Day Low | 76.195 |
| Debt To Equity | 26.556 |
| Display Name | LivaNova |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,822,400 |
| Earnings Call Timestamp Start | 1,793,822,400 |
| Earnings Growth | 2.878 |
| Earnings Quarterly Growth | 2.997 |
| Earnings Timestamp | 1,793,795,400 |
| Earnings Timestamp End | 1,793,795,400 |
| Earnings Timestamp Start | 1,793,795,400 |
| Ebitda | 260,138,000 |
| Ebitda Margins | 0.17678 |
| Enterprise To Ebitda | 15.992 |
| Enterprise To Revenue | 2.827 |
| Enterprise Value | 4,160,170,240 |
| Eps Current Year | 4.3561 |
| Eps Forward | 4.6833 |
| Eps Trailing Twelve Months | 3.38 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 44 1452 638 530 |
| Fifty Day Average | 78.3888 |
| Fifty Day Average Change | 0.111198425 |
| Fifty Day Average Change Percent | 0.0014185499 |
| Fifty Two Week Change Percent | 46.10088 |
| Fifty Two Week High | 85.76 |
| Fifty Two Week High Change | -7.260002 |
| Fifty Two Week High Change Percent | -0.084654875 |
| Fifty Two Week Low | 48.82 |
| Fifty Two Week Low Change | 29.68 |
| Fifty Two Week Low Change Percent | 0.6079476 |
| Fifty Two Week Range | 48.82 - 85.76 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,445,261,400,000 |
| Float Shares | 54,836,771 |
| Forward Eps | 4.6833 |
| Forward P E | 16.761684 |
| Free Cashflow | 59,872,624 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 3,300 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 78.5 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.67743 |
| Gross Profits | 996,846,976 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00414 |
| Held Percent Institutions | 1.1292601 |
| Implied Shares Outstanding | 55,093,507 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom. |
| Long Name | LivaNova PLC |
| Market | us_market |
| Market Cap | 4,324,840,448 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_27283 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 188,552,992 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,254,320,610 |
| Number Of Analyst Opinions | 11 |
| Open | 76.9 |
| Operating Cashflow | 249,258,000 |
| Operating Margins | 0.13543999 |
| Overall Risk | 2 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.93 |
| Phone | 44 1452 638 500 |
| Pre Market Change | 0.0 |
| Pre Market Change Percent | 0.0 |
| Pre Market Price | 78.5 |
| Pre Market Time | 1,792,140,345 |
| Previous Close | 76.08 |
| Price Eps Current Year | 18.020706 |
| Price Hint | 2 |
| Price To Book | 3.2607794 |
| Price To Sales Trailing12 Months | 2.9390314 |
| Profit Margins | 0.12813 |
| Quick Ratio | 1.079 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.63636 |
| Region | US |
| Regular Market Change | 2.42 |
| Regular Market Change Percent | 3.18086 |
| Regular Market Day High | 79.11 |
| Regular Market Day Low | 76.195 |
| Regular Market Day Range | 76.195 - 79.11 |
| Regular Market Open | 76.9 |
| Regular Market Previous Close | 76.08 |
| Regular Market Price | 78.5 |
| Regular Market Time | 1,792,094,401 |
| Regular Market Volume | 737,955 |
| Return On Assets | 0.0504 |
| Return On Equity | 0.15404001 |
| Revenue Growth | 0.108 |
| Revenue Per Share | 26.895 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 55,093,507 |
| Shares Percent Shares Out | 0.109 |
| Shares Short | 6,003,050 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 4,987,757 |
| Short Name | LivaNova PLC |
| Short Percent Of Float | 0.1251 |
| Short Ratio | 9.07 |
| Source Interval | 15 |
| Symbol | LIVN |
| Target High Price | 105.0 |
| Target Low Price | 75.0 |
| Target Mean Price | 90.54545 |
| Target Median Price | 93.0 |
| Total Cash | 516,619,008 |
| Total Cash Per Share | 9.377 |
| Total Debt | 351,948,992 |
| Total Revenue | 1,471,518,976 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 3.38 |
| Trailing P E | 23.224852 |
| Trailing Peg Ratio | 0.9256 |
| Triggerable | 1 |
| Two Hundred Day Average | 71.96213 |
| Two Hundred Day Average Change | 6.5378723 |
| Two Hundred Day Average Change Percent | 0.09085157 |
| Type Disp | Equity |
| Volume | 737,955 |
| Website | https://www.livanova.com |
| Zip | GL3 4FE |